Global Poliomyelitis Vaccine In Dragee Candy Market Size By End-User (Clinics, Hospitals), By Competitive Landscape, By Geographic Scope And Forecast

Poliomyelitis Vaccine In Dragee Candy Market Size And Forecast

Poliomyelitis Vaccine In Dragee Candy Market size was valued at USD 67.2 Billion in 2022 and is projected to reach USD 161.07 Billion by 2030, growing at a CAGR of 10.2% from 2023 to 2030.

The increasing number of improvements in technology and research studies are directly contributing to the enormous boom that the Poliomyelitis Vaccine In Dragee Candy Market is currently undergoing. The incidence of poliomyelitis is also increasing, which is another aspect to consider. Another significant aspect that is contributing to the expansion of the market is the involvement of the government in the research and development of vaccines as well as the dissemination of information among the general population. The Global Poliomyelitis Vaccine In Dragee Candy Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Poliomyelitis Vaccine In Dragee Candy Market Definition

The human enterovirus known as poliovirus is the causative agent of an acute form of the infectious disease known as poliomyelitis. Oral contact with secretions or feces that have been produced by an infected person is the most common method of poliovirus transmission from one person to another. According to a report published by the World Health Organization (WHO) in March 2018, the number of cases of wild-type poliovirus has fallen by more than 99 percent since 1988. In spite of the fact that the majority of countries, including the United States and India, are free of polio, endemic transmission of the virus is still occurring in Afghanistan, Nigeria, and Pakistan due to failures in the implementation of strategic approaches, such as the administration of the appropriate immunization.

As a result of these reasons, there is a growing demand for more advanced oomycetes vaccines for the treatment of disease, which is anticipated to fuel growth in the market. Oral polio vaccinations induce around three incidences of vaccine-associated paralytic poliomyelitis for every million doses administered. All children should be fully vaccinated against polio, according to the World Health Organization (WHO). Vaccines in the shape of candy, such as dragee candy, are a colorful covered sweet with a hard outer shell and softer core that is widely used for decorating as well as eating.

The Poliomyelitis Vaccine included in Dragee Candy is administered to patients in order to protect them from contracting the disease that is brought on by the poliovirus. Polio vaccines are administered mostly to children as a method of preventing the transmission of the polio virus. Oral poliovirus vaccine, also known as OPV, and inactivated poliovirus vaccine are the two varieties of immunizations available (IPV). It is possible for it to induce meningitis, which is an irritation of the lining of the brain, as well as paralysis, which is the inability to move the arms or legs. It has a wide range of applications in the medical field, including in clinics, hospitals, and other types of medical facilities.

Global Poliomyelitis Vaccine In Dragee Candy Market Overview

The increasing number of improvements in technology and research studies are directly contributing to the enormous boom that the Poliomyelitis Vaccine In Dragee Candy Market is currently undergoing. The incidence of poliomyelitis is also increasing, which is another aspect to consider. Another significant aspect that is contributing to the expansion of the market is the involvement of the government in the research and development of vaccines as well as the dissemination of information among the general population. The Poliomyelitis Vaccine In Dragee Candy Market is anticipated to expand at a faster rate as a result of an increasing number of mergers and acquisitions involving key players in the business of poliovirus vaccines. For example, in April of 2017, Serum Institute of India Pvt. Ltd. paid a total of US $ 82.08 million to purchase Nanotherapeutics, a company based in the Czech Republic.

Because of this acquisition, Serum Institute was able to increase its capacity to make injectable polio vaccine to 200 million dosages, making it the largest manufacturer of polio vaccinations in the world. Additionally, in July of 2018, Bharat Biotech made an announcement that they will be developing a polio vaccine that would protect against type I and type III viruses. Bharat Biotech is interested in developing combination vaccinations that include the Sabin Inactivated Polio Vaccine (sIPV) in the hopes of successfully eradicating the poliovirus. It is anticipated that the robust manufacturing of vaccinations against poliovirus would contribute to the expansion of the market.

On the other hand, the fact that there are alternatives available and a general lack of understanding among the populace is likely to stymie the expansion of the industry. Product recalls are being initiated as a direct result of significant breaches in sterile conditions, which is slowing the expansion of the oomycetes vaccine industry. For example, in October of 2018, the Ministry of Health and Family Welfare of India ordered the recall of all batches of bivalent oral polio vaccination vials that were manufactured by Bio-Med Limited. The oral bivalent polio vaccine protects against two distinct viral strains. Children were infected as a result of a particular batch that was tainted with type II poliovirus.

Global Poliomyelitis Vaccine In Dragee Candy MarketSegmentation Analysis

The Global Poliomyelitis Vaccine In Dragee Candy Market is Segmented on the basis of End-User and Geography.

Poliomyelitis Vaccine In Dragee Candy Market, By End-User

• Clinics• Hospitals• Others

Based on End-User, the market is segmented into Clinics, Hospitals, and Others. It is anticipated that the hospital will hold the majority of the market share. This is mostly due to an increase in the number of hospitals, which has resulted in a shorter waiting period. In addition, the increasing number of government programs to give better medical care to patients in hospitals is another factor that contributes to this sector’s dominant market position. In addition, the number of medical centers is anticipated to expand at the fastest CAGR. This is because medical centers offer appropriate vaccinations and employ skilled health workers who have received adequate training.

Poliomyelitis Vaccine In Dragee Candy Market, By Geography

• North America• Europe• Asia Pacific• Rest of the World

Based on Geography, the Poliomyelitis Vaccine In Dragee Candy Market is classified into North America, Europe, Asia Pacific, and the Rest of the world in 2021. The Asia-Pacific region held the lion’s share of the market for poliomyelitis vaccine in dragee candy, accounting for 41 percent of the total market. This is primarily attributable to the expanding efforts made by the government toward awareness and vaccination. For example, in 2018, the government of India carried out widespread vaccination programs against polio in order to maintain a high level of protection against the disease by utilizing the bivalent oral polio vaccine (bOPV). In addition, the Ministry of Health and Family Welfare in India is focusing on mobile and migratory populations in an effort to stop the spread of the polio virus from neighboring countries such as Nepal, Pakistan, and Bangladesh. However, during the course of the forecast period, it is anticipated that the region of North America will have the most growth. This is a result of increasing expenditures on healthcare as well as increased advances in technological advancements within the vaccination industry.

Key Players

The “Global Poliomyelitis Vaccine In Dragee Candy Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Sanofi S.A, United Pharma Industries Co Ltd, Gansu Conbest Biotech Co., Ltd., Shenzhen Mellow Hope Pharm Industrial Co., Ltd., and China National Biotec Group. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Pfizer Inc. paid $48 per share in cash for Array Biopharma in June 2019, for a total enterprise value of about $11.4 billion. Pfizer’s innovative biopharmaceutical business will benefit from this acquisition.

Report Scope

Top Trending Reports

Research Methodology of Market Research